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Abstract
The recognition of bacterial lipopolysaccharide (LPS) by host Toll-like receptor (TLR)4 is a crucial step in developing
protective immunity against several gram negative bacterial pathogens. Bordetella bronchiseptica and B. pertussis stimulate
robust TLR4 responses that are required to control the infection, but a close relative, B. parapertussis, poorly stimulates this
receptor, and TLR4 deficiency does not affect its course of infection. This led us to hypothesize that inefficient TLR4
stimulation enables B. parapertussis to evade host immunity. In a mouse model of infection, B. parapertussis grew rapidly in
the lungs, but no measurable increase in TLR4-mediated cytokine, chemokine, or leukocyte responses were observed over
the first few days of infection. Delivery of a TLR4 stimulant in the inoculum resulted in a robust inflammatory response and a
10- to 100-fold reduction of B. parapertussis numbers. As we have previously shown, B. parapertussis grows efficiently during
the first week of infection even in animals passively immunized with antibodies. We show that this evasion of antibody-
mediated clearance is dependent on the lack of TLR4 stimulation by B. parapertussis as co-inoculation with a TLR4 agonist
resulted in 10,000-fold lower B. parapertussis numbers on day 3 in antibody-treated wild type, but not TLR4-deficient, mice.
Together, these results indicate that inefficient TLR4 stimulation by B. parapertussis enables it to avoid host immunity and
grow to high numbers in the respiratory tract of naı ¨ve and immunized hosts.
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Introduction
The ability of a pathogen to persist in its host for an extended
period of time requires that it first evades rapid control and
clearance by the innate immune response. Lipopolysaccharide
(LPS), a major component of the outer membrane of gram
negative bacteria, stimulates host Toll-like receptor (TLR)4 to
initiate the production of pro-inflammatory cytokines and
chemokines that recruit and activate leukocytes [1,2], which is
important to protection against many bacterial pathogens
[3,4,5,6,7,8]. Interestingly, LPS is not an invariant structure
among gram negative bacteria. For example, Salmonella deacylates
and palmitoylates lipid A in response to the host environment,
allowing this bacterium to evade TLR4 responses [9,10]. Yersinia
and Pseudomonas species also modulate their LPS structures,
resulting in diminished TLR4 responses to infection
[11,12,13,14]. These findings have led to the recent realization
that bacteria can modulate pathogen associated molecular
patterns, such as LPS, to optimize interactions with the host.
Bordetella bronchiseptica, B. pertussis and B. parapertussis are three
very closely related species that make up the classical bordetellae.
Bordetella bronchiseptica, infects a wide-range of mammals where it
chronically colonizes the nasal cavity [15] and is often observed as
a commensal [16,17]. Both B. pertussis and B. parapertussis are highly
infectious pathogens that cause the acute disease whooping cough
in humans [16]. Each of these human-adapted species has
independently evolved from a B. bronchiseptica-like progenitor
[18,19]. The comparative immunobiology of the bordetellae has
shed light on some key differences among these bacteria. For
example, the LPS structures of each of these bordetellae differs
[20,21,22] which results in a wide-range of TLR4 responses and
requirements [3]. The LPS of B. pertussis and B. bronchiseptica are
very stimulatory of TLR4 and TLR4 is required for their
clearance [3]. In contrast, the LPS of B. parapertussis LPS is much
less stimulatory of TLR4 and TLR4-deficiency does not render
mice more susceptible to B. parapertussis [3].
The clearance of these Bordetella species by antibodies also differs
and appears to relate to their epidemiology [15]. B. bronchiseptica is
rapidly cleared, three days post-inoculation, by adoptively
transferred antibodies [15]. Previous studies have shown that this
rapid antibody-mediated clearance is due to TLR4-dependent
leukocyte recruitment [23]. B. bronchiseptica can persist for years
within the nasal cavity of its host, where serum antibodies have no
effect, and therefore a strong selection to avoid antibody-mediated
clearance does not exist [15]. In contrast to B. bronchiseptica, B.
pertussis and B. parapertussis avoid rapid antibody-mediated
clearance for the first week of infection until a sufficient T-cell
response is generated [15,24]. Therefore, while both B. pertussis
and B. parapertussis are more closely related to B. bronchiseptica than
they are to each other [18], they share the ability to resist rapid
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high prevalence of detectable antibodies to B. pertussis and B.
parapertussis in human populations, either due to vaccination or
previous infection, presents a strong selection for the ability to
avoid antibody-mediated clearance, allowing for repeated infec-
tion of individuals [15].
While both of these human-adapted species avoid rapid antibody-
mediated clearance, they do so by distinct mechanisms. B. pertussis
avoids rapid antibody-mediated clearance by inhibiting the TLR4-
dependent recruitment of leukocytes to the lungs via pertussis toxin
(Ptx) [25,26]. A strain lacking Ptx (B. pertussisDPTx) is rapidly cleared
from the lungs upon adoptive transfer of antibodies [25]. Since B.
parapertussis lacks Ptx [27], this bacterium must avoid antibody-
mediated clearance in a Ptx-independent manner.
Since the rapid antibody-mediated clearance of B. bronchiseptica
is dependent on TLR4 [23] and B. parapertussis is a weak stimulator
of TLR4 [3], we hypothesized that the inefficient TLR4
stimulation by B. parapertussis allows it to avoid the robust
inflammatory response required for rapid antibody-mediated
clearance. Using a mouse model of infection, we determined that
co-inoculation of B. parapertussis with a TLR4 stimulant led to
enhanced pro-inflammatory cytokine production and leukocyte
accumulation as well as more efficient control and rapid antibody-
mediated clearance of the bacteria. These results, observed in wild
type but not TLR4-deficient animals, explain several character-
istics of this important human pathogen and suggest interventions
in the disease process. They also demonstrate how very closely
related organisms can change complex structural components such
as LPS to modulate stimulation of innate immune receptors to
optimize their interactions with the host.
Materials and Methods
Bacterial strains and growth
B. parapertussis strain 12822 was isolated from German clinical
trials [28] and 12822G is a gentamicin-resistant derivative of
12822 [24]. B. bronchiseptica strain RB50 was originally isolated
from a rabbit [29]. Bacteria were maintained on Bordet-Gengou
agar (Difco) containing 10% defibrinated sheep blood (Hema
Resources) and appropriate antibiotics. Liquid culture bacteria
were grown at 37uC overnight on a roller drum to mid-log phase
in Stainer-Scholte broth.
Inoculation of mice
C57BL/6, C3H/HEOuJ (wild type), and C3H/HEJ (TLR4-
deficient) mice were obtained from Jackson Laboratories and bred
in our Bordetella-free, specific pathogen-free facilities at The
Pennsylvania State University. Bacteria grown overnight (to an
optical density at 600 nm of approximately 0.3) in liquid culture
were diluted in PBS to approximately 10
7 CFU/ml. 50 ml of the
inoculum (5610
5 CFU) was pipetted on to the external nares of 4–
6 week old mice that had been lightly sedated with 5% isoflurane
in oxygen. For co-inoculations with B. parapertussis and B.
bronchiseptica, both species were present at 10
7 CFU/ml in the
inoculum and mice were inoculated as above (5610
5 CFU of each
species in 50 ml). For co-inoculation with heat-killed B. bronchi-
septica, bacteria were grown overnight to an optical density of 0.3
and heat-inactivated by incubating in a water bath at 75uC for
30 minutes. Bacteria in the inoculum were plated before and after
heat-inactivation to quantify the number of bacteria present and
ensure that the incubation killed B. bronchiseptica. Inocula were
prepared so that they contained 10
7 CFU/ml of B. parapertussis and
10
9 CFU/ml of heat-killed B. bronchiseptica (5610
5 CFU B.
parapertussis and 5610
7 CFU of heat-killed B. bronchiseptica in
50 ml per mouse). For co-inoculations with LPS, inocula were
prepared containing 10
7 CFU/ml of B. parapertussis and 10 mg/ml
of purified LPS from B. bronchiseptica, B. parapertussis,o rE. coli
(5610
5 CFU B. parapertussis and 500 ng LPS in 50 ml per mouse).
All protocols were reviewed by the university’s Institutional
Animal Care and Use Committee and all animals were handled
in accordance with institutional guidelines.
Adoptive transfer of serum antibodies
To generate convalescent phase (immune) serum, C57BL/6
mice were inoculated with 5610
5 CFU of B. parapertussis and
allowed to convalesce for 28 days. By this time, these mice have
generated high titers of B. parapertussis-specific antibodies [24].
Blood was then collected from these mice and the serum portion
was isolated and stored at 280uC until use. 200 ml of immune
serum was delivered by I.P. injection into mice immediately before
inoculation. Serum from uninfected mice (naı ¨ve serum) was used
as a control.
Quantification of bacteria, leukocytes, and cytokines in
the lungs
To quantify bacterial numbers, the lungs were excised on day 0,
0.5, 1, 2, 3, 7, or 14 post-inoculation. Lungs were homogenized in
1 ml of PBS. The lung homogenate was then plated onto Bordet-
Gengou agar plates at the appropriate dilutions and CFU were
counted 4 days later for B. parapertussis and 2 days later for B.
bronchiseptica. To quantify leukocytes, mice were infected for 0, 0.5,
1, 2, 3, 7, or 14 days, sacrificed, and bronchoalveolar lavage (BAL)
fluid was collected. Red blood cells were lysed by treatment with
ammonium chloride as previously described [30]. Leukocytes were
counted on a hemocytometer to quantify total numbers of
leukocytes in the BAL fluid. Aliquots of cells were stained with
FITC-labeled anti-Ly-6G (BD Biosciences Phramingen), and the
percentage of Ly-6G positive cells was multiplied by the total
number of leukocytes to calculate the number of neutrophils. For
the quantification of cytokines and chemokines in the lungs, wild
type or TLR4-deficient mice were inoculated with B. parapertussis,
B. bronchiseptica, or both species and sacrificed 2 hours or 1 day
later. Lungs were homogenized in 1 mL of PBS and samples were
run on ELISAs specific for TNFa, KC, MIP-1a, and/or IL-1b
according to the manufacturer’s protocols (R&D Systems,
Minneapolis, Minnesota, USA).
In vitro growth curves of B. parapertussis and B.
bronchiseptica and enumeration of co-inoculated
samples
Both bacteria (RB50 and 12822G) were grown overnight to an
optical density of 0.3. They were then diluted in fresh Stainer-
Scholte broth to 10
7 CFU/ml. The liquid cultures were then
grown on a roller drum at 37uC and aliquots were plated at the
indicated times on Bordet-Gengou agar plates with 20 mg/ml of
streptomycin or gentamicin. The streptomycin plates, on which
both species could have grown, were counted 2 days later, before
B. parapertussis colonies became visible. The gentamicin plates, on
which only B. parapertussis could grow, were counted 4 days later.
Statistical Analysis
The mean+/2SD (error bars) was determined for CFU,
leukocytes, and cytokines. For experiments quantifying bacterial
numbers, either three or four mice were used per group. For all
other experiments, four mice were used per group. Two-tailed,
unpaired Student’s T-tests were used to determine statistical
significance between groups. All experiments were performed at
B. parapertussis Immune Evasion
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statistically significant.
Results
Reduction of B. parapertussis numbers correlates with an
accumulation of leukocytes in the lungs
B. parapertussis grows rapidly over the first few days post-
inoculation but does not induce an early recruitment of
neutrophils, which are known to be essential to eliminating this
pathogen [3,24]. Therefore, we sought to determine if the eventual
reduction of B. parapertussis numbers in the lungs correlates with a
delayed accumulation of neutrophils. C57BL/6 mice were
inoculated with B. parapertussis and sacrificed on days 0, 3, 7, or
14 post-inoculation to quantify the numbers of bacteria in the
lungs. B. parapertussis numbers peaked at approximately 4610
6
CFU on day 3, but began to decline by day 7 and were reduced to
6610
3 CFU by day 14 post-inoculation (Fig. 1A). Groups of
C57BL/6 mice were also sacrificed on days 0, 3, 7, or 14 post-
inoculation to quantify the numbers of leukocytes in the BAL fluid.
Approximately 6610
4 leukocytes and less than 1610
4 neutrophils
were recovered from the BAL fluid of uninfected mice. Leukocyte
numbers had slightly, but significantly, increased by day 3 post-
inoculation (1.6610
5 leukocytes, 1610
5 neutrophils), and peaked
on day 7 post-inoculation (6610
5 leukocytes, 2610
5 neutrophils),
declining thereafter (Fig. 1B). Together, these data show that the
time when B. parapertussis numbers began to decline in murine
lungs correlated with peak numbers of neutrophils in the lungs.
B. parapertussis does not induce an early, TLR4-mediated
leukocyte response
Although the induction of TLR4 responses is crucial to
protection against other Bordetella species, B. parapertussis LPS does
not efficiently stimulate these responses [3]. We addressed whether
or not this pathogen induces any TLR4-dependent recruitment of
leukocytes to the lungs over the course of infection. Wild type
(C3H/HEOuJ) and TLR4-deficient (C3H/HEJ) mice were
inoculated with B. parapertussis and sacrificed 0, 2 hours, 1, 3, 7,
or 14 days later to quantify the numbers of bacteria in the lungs
and leukocytes in the BAL fluid. As previously shown, similar
bacterial numbers were observed in wild type and TLR4-deficient
mice [3] (Fig. 2A). In the lungs of wild type mice, leukocyte
numbers were highest on day 7 post-inoculation (,3610
5 cells),
and the same was true for TLR4-deficient mice (,6610
5 cells)
(Fig. 2B). Fewer than 10
5 neutrophils were found in the lungs of
both wild type and TLR4-deficient mice over the first 3 days post-
inoculation but peaked on day 7 in both wild type (,2610
5 cells)
Figure 1. Numbers of B. parapertussis and leukocytes in the
lungs over time. Groups of C57BL/6 mice were inoculated with B.
parapertussis and sacrificed on day 0, 3, 7, or 14 post-inoculation. (A)
Bacterial numbers in the lungs are represented as the Log10 mean+/
2S.D. The dashed line represents the lower limit of detection. (B)
Leukocyte and neutrophil numbers in the BAL fluid are represented as
the mean+/2SD and asterisks denote P-values,0.05 when compared
to numbers at day 3 for CFU (the highest observed numbers) or day 0
(naı ¨ve mice) for leukocytes.
doi:10.1371/journal.pone.0004280.g001
Figure 2. Numbers of leukocytes in the lungs of wild type and
TLR4-deficient mice upon B. parapertussis infection. Groups of
C3H/HEOuJ (WT) and C3H/HEJ (TLR4-def) mice were inoculated with B.
parapertussis and sacrificed 2 hours later or on day 1, 3, 7, or 14 post-
inoculation. (A) Bacterial numbers in the lungs were quantified on days
3, 7, and 14 post-inoculation and are expressed as the Log10 mean+/
2SD. (B) Total leukocytes and (C) neutrophils in the BAL fluid were
quantified at all time points and are represented as the mean+/2S.D.
Asterisks denote P-values,0.05 when compared to naı ¨ve mice.
doi:10.1371/journal.pone.0004280.g002
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5 cells) mice (Fig. 2C). Interestingly,
more leukocytes accumulated in the lungs of TLR4-deficient mice
compared to wild type mice. Therefore, TLR4 signaling does not
measurably enhance the recruitment of leukocytes or the control
of B. parapertussis infection, but may affect anti-inflammatory
signals in response to this bacterium.
TLR4-mediated cytokine and chemokine responses are
not inhibited by B. parapertussis during infection of mice
The lack of a measurable TLR4-mediated accumulation of
leukocytes in response to B. parapertussis (Fig. 2) led us to assess
whether or not B. parapertussis actively inhibits TLR4-mediated
cytokine production. For these experiments, the effects of B.
parapertussis on TLR4-mediated responses to a respiratory
pathogen that is closely related and a potent stimulator of
TLR4, B. bronchiseptica, were examined. Wild type and TLR4-
deficient mice were inoculated with B. parapertussis, B. bronchiseptica,
or both bacteria and sacrificed 2 hours later. B. parapertussis did not
induce significant levels of TNF-a, KC, or MIP-1a in wild type or
TLR4-deficient mice relative to mock-infected controls (Fig. 3A–
C). Approximately 1000 pg of IL-1b was produced in the lungs of
wild type mice in response to B. parapertussis, but this was not
significantly different from the amount produced by TLR4-
deficient mice (Fig. 3D). B. bronchiseptica induced the production of
approximately 3000 pg of TNF-a, 3500 pg of KC, 9000 pg of
MIP-1a, and 2300 pg of IL-1b in the lungs of wild type mice, but
much lower levels in TLR4-deficient mice (250, 125, 200, and
1200 pg respectively) (Fig. 3A–D). Similar to B. bronchiseptica, the
lungs of wild type mice that were inoculated with both species
contained approximately 3500 pg of TNF-a,4500 pg of KC,
8500 pg of MIP-1a, and 2400 pg of IL-1b, and this production
was also dependent on TLR4 (Fig. 3A–D). Together, these data
indicate that B. parapertussis does not stimulate TLR4 or inhibit the
TLR4-mediated cytokine and chemokine responses to B. bronch-
iseptica infection.
Co-inoculation with B. bronchiseptica allows for more
efficient control of B. parapertussis
The robust, TLR4-mediated cytokine and chemokine responses
to a co-inoculation with B. parapertussis and B. bronchiseptica led us to
examine the effect of the co-inoculation on the accumulation of
leukocytes and clearance of these bacteria. Wild type mice were
inoculated with B. parapertussis, B. bronchiseptica, or both species and
sacrificed 12 hours, 1, 2, or 3 days later to quantify neutrophils in
the BAL fluid. Consistent with Figures 1 and 2, the BAL fluid of B.
parapertussis-infected mice contained few neutrophils (,10
5/ml of
BAL fluid) over the first three days post-inoculation (Fig. 4A). In
contrast, B. bronchiseptica induced the accumulation of approxi-
mately 1.5610
6 neutrophils/ml of BAL fluid over the first two
days. This early recruitment of neutrophils to the lungs upon B.
bronchiseptica infection is dependent on TLR4 [3]. The BAL fluid of
co-inoculated mice also contained approximately 1.5610
6 neu-
trophils/ml for the first two days (Fig. 4A), indicating that B.
parapertussis did not measurably inhibit the TLR4-mediated
recruitment of neutrophils to the lungs in response to B.
bronchiseptica infection.
Groups of C57BL/6 mice were then inoculated with B.
parapertussis, B. bronchiseptica, or both bacteria and sacrificed
12 hours, 1, 2, or 3 days later to quantify bacterial numbers in
the lungs. B. bronchiseptica numbers were not affected by a co-
inoculation with B. parapertussis (Fig. 4B). When inoculated alone,
B. parapertussis numbers rose over the first three days, peaking at
approximately 3610
6 CFU on day 3 post-inoculation. When co-
inoculated with B. bronchiseptica, however, B. parapertussis numbers
began to decline after one day and were reduced to
approximately 5610
4 CFU by day 3 post-inoculation, a 99%
reduction from numbers of B. parapertussis alone (Fig. 4C).
Together, these data indicate that a co-infection with B.
bronchiseptica results in increased neutrophil recruitment and
more efficient control of B. parapertussis.
To determine if B. parapertussis and B. bronchiseptica directly
affected the growth of one another, they were grown together in
liquid culture. B. bronchiseptica grew from approximately 10
7 CFU/
ml to 10
11 CFU/ml in 24 hours and its growth was not affected by
a co-inoculation with B. parapertussis (data not shown). B.
parapertussis, which grows slower than B. bronchiseptica, grew from
approximately 10
7 CFU/ml to 10
10 CFU/ml in 24 hours and its
growth rate was not affected by a co-inoculation with B.
bronchiseptica (data not shown). Thus, B. parapertussis and B.
bronchiseptica do not directly affect each other’s growth, even when
grown to high density in vitro.
Co-inoculation with B. bronchiseptica results in rapid
antibody-mediated clearance of B. parapertussis
B. bronchiseptica is cleared by antibodies within about three days
via a TLR4-dependent mechanism [23]. In contrast, antibodies
have no effect on the course of B. parapertussis infection during the
first week but eliminate the infection during the second week
[15,24] (Fig. 5A), after significant numbers of neutrophils have
accumulated in the lungs. Thus, we hypothesized that the lack of
an early TLR4-mediated neutrophil recruitment allows B.
parapertussis to delay antibody-mediated clearance. To test this,
we examined the effect of stimulating TLR4 responses on the
rapid antibody-mediated clearance of B. parapertussis by inocu-
lating mice with one species or both species and giving an I.P.
injection of naı ¨ve serum or convalescent phase (immune) serum.
Groups of mice were then sacrificed on day 3 or 7 post-
inoculation for the enumeration of bacteria in the lungs. While
immune serum alone had no measurable effect on the numbers
Figure 3. Effect of a co-inoculation with B. parapertussis on the
TLR4-mediated cytokine response to B. bronchiseptica. Groups of
wild type C3H/HEOuJ and TLR4-deficient C3H/HEJ mice were inoculated
with B. parapertussis (Bpp), B. bronchiseptica (Bb), or both bacteria
(Bpp+Bb) and sacrificed 2 hours later for the quantification of (A) TNF-a,
(B) KC, (C) MIP-1a, or (D) IL-1b in lungs homogenized in 1 mL of PBS.
Cytokine and chemokine numbers are expressed as the mean+/2SD.
Asterisks represent P-values,0.05 when compared to mock-infected
mice.
doi:10.1371/journal.pone.0004280.g003
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inoculation of B. bronchiseptica rapidly reduced B. parapertussis
numbers .99%, to approximately 100 CFU by day 3 and to
undetectable levels by day 7 post-inoculation (Fig. 5B). These
data indicate that a co-inoculation with B. bronchiseptica results in
rapid antibody-mediated clearance of B. parapertussis.T h ec o -
inoculation did not affect the ability of B. bronchiseptica to colonize
the lungs of mice treated with naı ¨ve serum, but B. bronchiseptica
numbers were approximately 500-fold lower in the lungs of mice
treated with immune serum (Fig. 5C). This was likely due to B.
parapertussis-induced antibodies being cross reactive with B.
bronchiseptica antigens.
Rapid clearance of B. parapertussis upon co-inoculation
with B. bronchiseptica is dependent on TLR4
We hypothesized that the protective effects of adding B.
bronchiseptica to the B. parapertussis inoculum were due to the robust
TLR4-mediated inflammatory response to B. bronchiseptica. To test
this, groups of wild type and TLR4-deficient mice were inoculated
with B. parapertussis alone or B. parapertussis with heat-killed B.
bronchiseptica. Heat-killed B. bronchiseptica was used because live B.
bronchiseptica is lethal to TLR4-deficient mice within approximately
3 days [3]. This also allowed us to address whether or not the effect
on B. parapertussis numbers required live B. bronchiseptica,o ri f
stimulation of the immune response by heat-inactivated compo-
Figure 4. In vivo growth of B. bronchiseptica on B. parapertussis upon a co-inoculation. (A) Groups of C57BL/6 mice were inoculated with B.
parapertussis (Bpp), B. bronchiseptica (Bb), or both bacteria (Bpp+Bb) and sacrificed 0.5, 1, 2, or 3 days later to quantify neutrophils in the BAL fluid.
Groups of mice were also sacrificed at these times to quantify (B) Bb numbers and (C) Bpp numbers in the lungs. Neutrophil numbers are expressed
as the mean+/2SD and bacterial numbers are expressed as the Log10 mean+/2SD. Asterisks represent P-values,0.05 when comparing B.
parapertussis-infected mice to co-infected mice.
doi:10.1371/journal.pone.0004280.g004
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leukocyte responses were measured 1 day post-inoculation with B.
parapertussis alone versus B. parapertussis with heat-killed B.
bronchiseptica. Inoculation with B. parapertussis did not induce levels
of TNFa and KC in the BAL fluid of wild type or TLR4-deficient
mice that were measurably different from mock-infected lungs
(Fig. 6A–B). In contrast, co-inoculation with B. parapertussis and
heat-killed B. bronchiseptica resulted in high levels of TLR4-
dependent TNFa and KC production (approximately 550 and
300 pg respectively). When leukocyte numbers were examined, B.
parapertussis alone did not induce significant levels of leukocyte
accumulation (,1610
5 leukocytes, ,2610
4 neutrophils) relative
to mock-infected mice (Fig. 6C–D). Co-inoculation with heat-
killed B. bronchiseptica, however, resulted in the accumulation of
8610
5 leukocytes and 6610
5 neutrophils in the lungs of wild type
mice by this time, while the lungs of TLR4-deficient mice
contained only 3610
5 leukocytes and 4610
4 neutrophils (Fig. 6C–
D). Thus, heat-killed B. bronchiseptica induced robust, TLR4-
mediated cytokine and leukocyte responses.
To address the effect on bacterial numbers, wild type and
TLR4-deficient mice were then inoculated with B. parapertussis
alone or B. parapertussis with heat-killed B. bronchiseptica. These mice
were also given an I.P. injection of naı ¨ve serum or immune serum
and sacrificed 3 days later. In wild type mice that were treated with
naı ¨ve serum, co-inoculation with heat-killed B. bronchiseptica
resulted in a 10-fold reduction of B. parapertussis numbers. In wild
type mice that were treated with immune serum, the co-
inoculation resulted in B. parapertussis numbers being reduced to
nearly undetectable levels within 3 days (Fig. 7A). In TLR4-
deficient mice, however, the co-inoculation had no effect on B.
parapertussis numbers in either naı ¨ve serum treated or immune
serum treated mice (Fig. 7A). Wild type and TLR4-deficient mice
were then inoculated with B. parapertussis and purified LPS from B.
bronchiseptica, E. coli,o rB. parapertussis to determine if the addition of
TLR4 stimulatory LPS was the key to rapid clearance of B.
parapertussis. Co-inoculation with B. bronchiseptica LPS resulted in a
10,000-fold reduction in bacterial numbers in the lungs of wild
type mice treated with immune serum, but did not affect bacterial
numbers in TLR4-deficient mice (Fig. 7B). Similar results were
observed when mice were co-inoculated with LPS from E. coli
(Fig. 7C). In contrast, co-inoculation with purified LPS from B.
parapertussis, a weak TLR4-stimulant [3], had no effect on B.
parapertussis numbers in the lungs of wild type or TLR4-deficient
Figure 5. Antibody-mediated clearance of B. parapertussis upon
a co-inoculation with B. bronchiseptica. (A) C57BL/6 mice were
inoculated with B. parapertussis, given an adoptive transfer of naı ¨ve
serum (NS) or immune serum (IS), and sacrificed 0, 3, 7, or 14 days later
to quantify bacterial numbers in the lungs. (B–C) C57BL/6 mice were
inoculated with B. parapertussis (Bpp), B. bronchiseptica (Bb), or both
bacteria (Bpp+Bb), given an adoptive transfer of naı ¨ve serum (NS) or
immune serum (IS), and sacrificed 3 or 7 days later. Numbers of (B) B.
parapertussis and (C) B. bronchiseptica in the lungs were quantified.
Bacterial numbers are expressed as the Log10 mean+/2SD. Asterisks
represent P-values,0.05.
doi:10.1371/journal.pone.0004280.g005
Figure 6. Cytokine and leukocyte levels in the lungs of mice
infected with B. parapertussis and heat-killed B. bronchiseptica.
Groups of wild type (C3H/HEOuJ) and TLR4-deficient (C3H/HEJ) mice
were inoculated with PBS, B. parapertussis (Bpp) or Bpp and heat-killed
B. bronchiseptica (HK Bb). (A) TNFa, (B) KC, (C) leukocyte and (D)
neutrophil levels were quantified in the BAL fluid one day later.
Cytokine levels and cell numbers are represented as the mean+/2SD.
Asterisks represent P-values,0.05 when compared to mock-infected
mice.
doi:10.1371/journal.pone.0004280.g006
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clearance of B. parapertussis upon co-inoculation with strong TLR4
stimulants (Fig. 7B–C). Combined, these data suggest that a lack of
TLR4 stimulation enables B. parapertussis to avoid immune
clearance and grow to higher numbers within the host.
Discussion
B. parapertussis is able to delay clearance by avoiding the
induction of a robust innate immune response. Here, we show that
its slow clearance from murine lungs correlates with the
accumulation of neutrophils in these lungs, which is delayed in
comparison to the neutrophil responses to other closely related
bacteria (Mann, Harvill, unpublished data). We predicted that
inefficient TLR4 stimulation by B. parapertussis LPS may result in
the low level of neutrophil accumulation in response to infection
over the first few days and may allow this pathogen to grow rapidly
during this time, even in animals given a passive transfer of
immune serum. In support of this, co-inoculation with a potent
stimulator of TLR4 resulted in enhanced control and rapid
antibody-mediated clearance of B. parapertussis from wild type, but
not TLR4-deficient mice. This study provides an example of how
expressing an LPS that is a poor stimulator of TLR4 can facilitate
persistence of a gram negative bacterium within its host.
LPS modulation is often utilized by gram negative bacterial
pathogens to optimize interactions with host immunity. For
example, Yersinia pestis produces a TLR4-stimulatory LPS at 26uC,
but an unstimulatory LPS at 37uC, the body temperature of its
typical mammalian host [11,12,13]. Montminy et.al. genetically
modified Y. pestis so that it would produce the stimulatory 26uC
LPS at all times [31]. While wild type Y. pestis causes sepsis and
mortality in a mouse model of infection, the expression of TLR4-
stimulatory LPS resulted in containment of the infection by the
innate immune response and less efficient systemic spread of the
infection [31]. Similarly, co-inoculation of B. parapertussis with a
TLR4 agonist resulted in an attenuated course of infection (Fig. 4,
Fig. 7). The expression of LPS molecules that poorly stimulate
TLR4 appears to hinder the generation of effective immunity
against Y. pestis [31] and B. parapertussis, and may be a stealth
strategy shared by other gram negative bacteria as well
[32,33,34,35].
TLR4 stimulation by LPS results in a branched downstream
signaling pathway consisting of a Mal/MyD88 branch and a
TRIF/TRAM branch that leads to the production of several
different pro-inflammatory cytokines [36]. However, each branch
is crucial to the production of a different subset of cytokines. For
example, TNF-a and CCL3 are MyD88-dependent cytokines
while IFN-b is a TRIF-dependent cytokine [37,38]. Although our
in vivo data presented above suggested that B. parapertussis does not
induce measurable amounts of TLR4-mediated cytokine produc-
tion or leukocyte recruitment (Fig.3, Fig. 6), the higher numbers of
leukocytes in TLR4-deficient mice suggests that leukocyte
responses to B. parapertussis infection may be limited by a TLR4-
dependent mechanism. B. parapertussis may upregulate the TRIF/
TRAM branch of TLR4 signaling, as this branch appears to play a
role in endotoxin tolerance [39]. We have also recently observed
that IL-10 dampens the inflammatory response to B. parapertussis in
vivo and induces the production of IL-10 in vitro (Wolfe and Hester,
unpublished data). Since IL-10 production can be induced by
TLR4 stimulation [4], it is reasonable to suggest that the anti-
inflammatory effect of TLR4 in Figure 2 may be mediated by IL-
10.
In contrast to B. bronchiseptica, passively transferred antibodies
have no effect on colonization by the human pathogens B.
parapertussis and B. pertussis over the first week of infection
[15,24,25]. This is likely important to the success of these
pathogens, as they are able to re-infect the same host multiple
times despite a measurable antibody response [40]. Our lab
previously showed that Ptx delays antibody-mediated clearance of
B. pertussis by inhibiting the migration of neutrophils to the lungs
[25]. Although B. parapertussis does not express Ptx, poor induction
of TLR4 signaling appears to be an alternative method for limiting
the neutrophil response and delaying antibody-mediated clear-
ance. Limiting and/or inhibiting pro-inflammatory TLR4 stimu-
lation may be crucial to the ability of B. parapertussis to remain
endemic in human populations.
In addition to the inefficient stimulation of pro-inflammatory
TLR4 responses [3], likely due to its lipid A structure, the O-
antigen of B. parapertussis LPS also appears to allow it to avoid
rapid clearance by antibodies induce by B. pertussis infection or
vaccination [24]. O-antigen prevents the binding of B. pertussis-
induced antibodies to the surface of B. parapertussis, allowing the
latter to colonize hosts that had been previously immunized
against the former. This provides an example of a single molecule,
LPS, providing multiple, non-overlapping mechanisms to protect a
bacterium against the effects of antibodies.
Despite excellent vaccine coverage, whooping cough has been
re-emerging in vaccinated populations [41,42,43,44,45], but it is
Figure 7. Effect of TLR4 stimulation on the rapid antibody-
mediated clearance of B. parapertussis. (A) Groups of wild type
(C3H/HEOuJ) and TLR4-deficient (C3H/HEJ) mice were inoculated with
B. parapertussis (Bpp) or Bpp and heat-killed B. bronchiseptica (HK Bb)
and given I.P. injections of naı ¨ve serum (NS) or immune serum (IS).
Groups of mice were also inoculated with Bpp and (B) Bb LPS (BbLPS) or
(C) E. coli LPS (EcLPS) and treated with naı ¨ve or immune serum. Bacterial
numbers were quantified 3 days later and are expressed as the Log10
mean+/2SD. Asterisks denote P-values,0.05.
doi:10.1371/journal.pone.0004280.g007
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in this resurgence [46]. Importantly, immunity induced by current
vaccines protects against B. pertussis disease, but is largely
ineffective against B. parapertussis disease [47,48,49,50,51]. The
widespread use of vaccines appears to have resulted in a higher
incidence of B. parapertussis as the causative agent of whooping
cough in vaccinated individuals relative to unvaccinated individ-
uals [49]. Current acellular vaccines induce a T cell response that
is Th2-skewed [52]. Given that our data shows that the clearance
of B. parapertussis by antibodies is enhanced by pro-inflammatory
responses, a vaccine that generates a strong Th1-skewed response
to B. parapertussis, as opposed to a partially cross-reactive Th2 type
response, could potentially provide more efficient protection
against this pathogen.
Acknowledgments
We would like to thank Elizabeth Goebel for critical reading and discussion
of this manuscript. We would also like to thank Dr. Sandeep Prabhu for the
use of materials and equipment.
Author Contributions
Conceived and designed the experiments: DNW AMB ETH. Performed
the experiments: DNW AMB. Analyzed the data: DNW AMB ETH.
Wrote the paper: DNW AMB ETH.
References
1. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev
Biochem 71: 635–700.
2. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, et al. (2000) Toll-like
receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
J Clin Invest 105: 497–504.
3. Mann PB, Wolfe D, Latz E, Golenbock D, Preston A, et al. (2005) Comparative
toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect
Immun 73: 8144–8152.
4. Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, et al. (2003) Toll-
like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T
cells and confers resistance to Bordetella pertussis by inhibiting inflammatory
pathology. J Immunol 171: 3119–3127.
5. Schurr JR, Young E, Byrne P, Steele C, Shellito JE, et al. (2005) Central role of
toll-like receptor 4 signaling and host defense in experimental pneumonia caused
by Gram-negative bacteria. Infect Immun 73: 532–545.
6. Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, et al. (2002) Toll-like
receptor 4 expression is required to control chronic Mycobacterium tuberculosis
infection in mice. J Immunol 169: 3155–3162.
7. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, et al. (2001) Protective
roles of mast cells against enterobacterial infection are mediated by Toll-like
receptor 4. J Immunol 167: 2250–2256.
8. Bernheiden M, Heinrich JM, Minigo G, Schutt C, Stelter F, et al. (2001) LBP,
CD14, TLR4 and the murine innate immune response to a peritoneal
Salmonella infection. J Endotoxin Res 7: 447–450.
9. Kawasaki K, Ernst RK, Miller SI (2004) 3-O-deacylation of lipid A by PagL, a
PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates
signaling through Toll-like receptor 4. J Biol Chem 279: 20044–20048.
10. Kawasaki K, Ernst RK, Miller SI (2004) Deacylation and palmitoylation of lipid
A by Salmonellae outer membrane enzymes modulate host signaling through
Toll-like receptor 4. J Endotoxin Res 10: 439–444.
11. Kawahara K, Tsukano H, Watanabe H, Lindner B, Matsuura M (2002)
Modification of the structure and activity of lipid A in Yersinia pestis
lipopolysaccharide by growth temperature. Infect Immun 70: 4092–4098.
12. Knirel YA, Lindner B, Vinogradov EV, Kocharova NA, Senchenkova SN, et al.
(2005) Temperature-dependent variations and intraspecies diversity of the
structure of the lipopolysaccharide of Yersinia pestis. Biochemistry 44:
1731–1743.
13. Rebeil R, Ernst RK, Gowen BB, Miller SI, Hinnebusch BJ (2004) Variation in
lipid A structure in the pathogenic yersiniae. Mol Microbiol 52: 1363–1373.
14. Ernst RK, Adams KN, Moskowitz SM, Kraig GM, Kawasaki K, et al. (2006)
The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss
within the cystic fibrosis airway. J Bacteriol 188: 191–201.
15. Kirimanjeswara GS, Mann PB, Harvill ET (2003) Role of antibodies in
immunity to Bordetella infections. Infect Immun 71: 1719–1724.
16. Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical
manifestations of respiratory infections due to Bordetella pertussis and other
Bordetella subspecies. Clin Microbiol Rev 18: 326–382.
17. Goodnow RA (1980) Biology of Bordetella bronchiseptica. Microbiol Rev 44:
722–738.
18. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, et al. (2003)
Comparative analysis of the genome sequences of Bordetella pertussis,
Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35: 32–40.
19. van der Zee A, Mooi F, Van Embden J, Musser J (1997) Molecular evolution
and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus
enzyme electrophoresis and typing with three insertion sequences. J Bacteriol
179: 6609–6617.
20. Preston A, Petersen BO, Duus JO, Kubler-Kielb J, Ben-Menachem G, et al.
(2006) Complete structures of Bordetella bronchiseptica and Bordetella
parapertussis lipopolysaccharides. J Biol Chem 281: 18135–18144.
21. van den Akker WM (1998) Lipopolysaccharide expression within the genus
Bordetella: influence of temperature and phase variation. Microbiology 144(Pt
6): 1527–1535.
22. Caroff M, Aussel L, Zarrouk H, Martin A, Richards JC, et al. (2001) Structural
variability and originality of the Bordetella endotoxins. J Endotoxin Res 7:
63–68.
23. Kirimanjeswara GS, Mann PB, Pilione M, Kennett MJ, Harvill ET (2005) The
complex mechanism of antibody-mediated clearance of Bordetella from the
lungs requires TLR4. J Immunol 175: 7504–7511.
24. Wolfe DN, Kirimanjeswara GS, Harvill ET (2005) Clearance of Bordetella
parapertussis from the lower respiratory tract requires humoral and cellular
immunity. Infect Immun 73: 6508–6513.
25. Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET (2005)
Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated
clearance of Bordetella pertussis. J Clin Invest 115: 3594–3601.
26. Carbonetti NH, Artamonova GV, Andreasen C, Bushar N (2005) Pertussis toxin
and adenylate cyclase toxin provide a one-two punch for establishment of
Bordetella pertussis infection of the respiratory tract. Infect Immun 73:
2698–2703.
27. Arico B, Rappuoli R (1987) Bordetella parapertussis and Bordetella bronchi-
septica contain transcriptionally silent pertussis toxin genes. J Bacteriol 169:
2847–2853.
28. Heininger U, Cotter PA, Fescemyer HW, Martinez de Tejada G, Yuk MH, et
al. (2002) Comparative phenotypic analysis of the Bordetella parapertussis isolate
chosen for genomic sequencing. Infect Immun 70: 3777–3784.
29. Cotter PA, Miller JF (1994) BvgAS-mediated signal transduction: analysis of
phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model.
Infect Immun 62: 3381–3390.
30. Pilione MR, Harvill ET (2006) The Bordetella bronchiseptica type III secretion
system inhibits gamma interferon production that is required for efficient
antibody-mediated bacterial clearance. Infect Immun 74: 1043–1049.
31. Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, et al. (2006)
Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide
response. Nat Immunol 7: 1066–1073.
32. Trent MS, Stead CM, Tran AX, Hankins JV (2006) Diversity of endotoxin and
its impact on pathogenesis. J Endotoxin Res 12: 205–223.
33. Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjostedt A, et al. (2006)
Lack of in vitro and in vivo recognition of Francisella tularensis subspecies
lipopolysaccharide by Toll-like receptors. Infect Immun 74: 6730–6738.
34. Dixon DR, Darveau RP (2005) Lipopolysaccharide heterogeneity: innate host
responses to bacterial modification of lipid a structure. J Dent Res 84: 584–595.
35. Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzman-Verri C, Chacon-
Diaz C, et al. (2007) Brucella abortus uses a stealthy strategy to avoid activation
of the innate immune system during the onset of infection. PLoS ONE 2: e631.
36. Palsson-McDermott EM, O’Neill LA (2004) Signal transduction by the
lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113: 153–162.
37. Kielian T, Phulwani NK, Esen N, Syed MM, Haney AC, et al. (2007) MyD88-
dependent signals are essential for the host immune response in experimental
brain abscess. J Immunol 178: 4528–4537.
38. Lee JY, Lowell CA, Lemay DG, Youn HS, Rhee SH, et al. (2005) The
regulation of the expression of inducible nitric oxide synthase by Src-family
tyrosine kinases mediated through MyD88-independent signaling pathways of
Toll-like receptor 4. Biochem Pharmacol 70: 1231–1240.
39. Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, et al. (2007) Role for
MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin
tolerance. J Immunol 179: 4083–4092.
40. Cherry JD, Heininger U (2004) Pertussis and other Bordetella infections. In
Textbook of pediatric infectious diseases, 5th ed. Feigin JDCRD, Demmler GJ,
Kaplan S, eds. Philadelphia: The W.B. Saunders Co. 1588 p.
41. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE (2005)
Resurgence of pertussis in Europe. Pediatr Infect Dis J 24: 761–765.
42. Center for Disease Control and Prevention (2002) Pertussis–United States,
1997–2000. JAMA. pp 977–979.
43. von Konig CH, Halperin S, Riffelmann M, Guiso N (2002) Pertussis of adults
and infants. Lancet Infect Dis 2: 744–750.
B. parapertussis Immune Evasion
PLoS ONE | www.plosone.org 8 January 2009 | Volume 4 | Issue 1 | e428044. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, et al. (2002) The
changing age and seasonal profile of pertussis in Canada. J Infect Dis 185:
1448–1453.
45. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, et al.
(2000) Reemergence of pertussis in the highly vaccinated population of the
Netherlands: observations on surveillance data. Emerg Infect Dis 6: 348–357.
46. Watanabe M, Nagai M (2004) Whooping cough due to Bordetella parapertussis:
an unresolved problem. Expert Rev Anti Infect Ther 2: 447–454.
47. Heininger U, Stehr K, Cherry JD (1998) The efficacy of a whole cell pertussis
vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis
infections in respiratory mouse model. Vaccine 16: 1255.
48. Willems RJ, Kamerbeek J, Geuijen CA, Top J, Gielen H, et al. (1998) The
efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis
and Bordetella parapertussis infections in a respiratory mouse model. Vaccine
16: 410–416.
49. Liese JG, Renner C, Stojanov S, Belohradsky BH (2003) Clinical and
epidemiological picture of B pertussis and B parapertussis infections after
introduction of acellular pertussis vaccines. Arch Dis Child 88: 684–687.
50. Stehr K, Cherry JD, Heininger U, Schmitt-Grohe S, uberall M, et al. (1998) A
comparative efficacy trial in Germany in infants who received either the
Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the
Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 101:
1–11.
51. David S, van Furth R, Mooi FR (2004) Efficacies of whole cell and acellular
pertussis vaccines against Bordetella parapertussis in a mouse model. Vaccine
22: 1892–1898.
52. Barnard A, Mahon BP, Watkins J, Redhead K, Mills KH (1996) Th1/Th2 cell
dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo
priming and in vitro cytokine detection techniques affect the classification of T-
cell subsets as Th1, Th2 or Th0. Immunology 87: 372–380.
B. parapertussis Immune Evasion
PLoS ONE | www.plosone.org 9 January 2009 | Volume 4 | Issue 1 | e4280